e-learning
resources
Copenhagen 2005
Tuesday 20.09.2005
Biology of tuberculosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Combined chemotherapy in
Mycobacterium avium
complex pulmonary disease
G. D. Pejovic, S. N. Golubovic, D. V. Dacic, M. M. Radovic (Nis, Serbia And Montenegro)
Source:
Annual Congress 2005 - Biology of tuberculosis
Session:
Biology of tuberculosis
Session type:
Thematic Poster Session
Number:
4159
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. D. Pejovic, S. N. Golubovic, D. V. Dacic, M. M. Radovic (Nis, Serbia And Montenegro). Combined chemotherapy in
Mycobacterium avium
complex pulmonary disease. Eur Respir J 2005; 26: Suppl. 49, 4159
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
Related content which might interest you:
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Paradoxical response during antibiotic treatment in patients with Mycobacterium avium complex lung disease
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020
The effect of combined chemotherapy according to the guidelines on the treatment for
Mycobacterium avium
complex pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 546s
Year: 2002
Management of
Mycobacterium avium
complex and
Mycobacterium abscessus
pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022
Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J, 54 (1) 1900118; 10.1183/13993003.00118-2019
Year: 2019
Long-term observation of pulmonary Mycobacterium avium complex disease treated with chemotherapy following the guidelines for treatment
Source: Annual Congress 2009 - Extrapulmonary tuberculosis and non-tuberculous-mycobacteria (NTM) infections
Year: 2009
Clinical analysis of pulmonary Mycobacterium avium complex disease in Japan
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
Source: Eur Respir J 2013; 42: 454-460
Year: 2013
Clinical features of pulmonary
Mycobacterium avium intracellulare
complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005
Long-term survival of patients with
mycobacterium avium- intracellulare
complex pulmonary disease (MAC-PD)
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Clinical analysis of pulmonary Mycobacterium kansasii disease
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Association between injectable aminoglycoside treatment duration and outcomes in cavitary Mycobacterium avium complex lung disease
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018
Outcomes of
Mycobacterium avium
complex lung disease based on clinical phenotype
Source: Eur Respir J, 50 (3) 1602503; 10.1183/13993003.02503-2016
Year: 2017
Factors related to response to intermittent treatment of
mycobacterium avium
complex lung disease
Source: Eur Respir J 2006; 28: Suppl. 50, 557s
Year: 2006
A case of familial pulmonary
Mycobacterium avium
complex disease – experience in Japan
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Mycobacterium xenopi pulmonary disease in Croatia
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012
Genome-wide association study in patients with pulmonary
Mycobacterium avium
complex disease
Source: Eur Respir J, 58 (2) 1902269; 10.1183/13993003.02269-2019
Year: 2021
Hospital-based antibiotic use in patients with
Mycobacterium avium
complex
Source: ERJ Open Res, 4 (4) 00109-2018; 10.1183/23120541.00109-2018
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept